SPY310.80-1.38 -0.44%
DIA262.95-0.22 -0.08%
IXIC9,602.92-80.00 -0.83%

SVB Leerink Maintains Outperform on Ascendis Pharma, Raises Price Target to $173

SVB Leerink maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $170 to $173.

Benzinga · 05/20/2020 13:50

SVB Leerink maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $170 to $173.